Ventilator-associated pneumonia caused by potentially drug-resistant bacteria

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 2, 1998, Pages 531-539

  Trouillet, Jean Louis ^a   Chastre, Jean ^a   Vuagnat, Albert ^a   Joly Guillou, Marie Laure ^a   Combaux, Danièle ^a   Dombret, Marie Christine ^a   Gibert, Claude ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFAMANDOLE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TIMENTIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; ASSISTED VENTILATION; BACTERIAL PNEUMONIA; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BRONCHOSCOPY; DRUG POTENCY; FEMALE; HOSPITAL INFECTION; HUMAN; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA;

EID: 0031886820     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.2.9705064     Document Type: Article

References (33)

1. Chastre, J., and J. Y. Fagon. 1994. Pneumonia in the ventilator-dependent patient. In M. J. Tobin, editor. Principles and Practice of Mechanical Ventilation. McGraw-Hill, New York. 857-890.
2. Craig, C. P., and S. Connelly. 1984. Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality. Am. J. Infect. Control 12:233-238.
3. Fagon, J. Y., J. Chastre, A. J. Hance, P. Montravers, A. Novara, and C. Gibert. 1993. Nosocomial pneumonia in ventilated patients. Am. J. Med. 94:281-288.
4. Fagon, J. Y., J. Chastre, A. Vuagnat, J. L. Trouillet, A. Novara, and C. Gibert. 1996. Nosocomial pneumonia and mortality among patients in intensive care units. J.A.M.A. 275:866-869.
5. Campbell, G. D., M. S. Niederman, W. A. Broughton, D. E. Craven, A. M. Fein, M. P. Fink, K. Gleeson, D. B. Hornick, J. P. Lynch, III, L. A. Mandell, C. M. Mason, A. Torres, and R. G. Wunderink. 1996. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement. Am. J. Respir. Crit. Care Med. 153:1711-1725.
6. Shaberg, D. R., D. H. Culver, and R. P. Gaynes. 1991. Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 91(Suppl. 3B):72S-75S.
7. Emori, T. G., and R. P. Gaynes. 1993. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin. Microbiol. Rev. 6:428-442.
8. Spencer, R. C. 1996. Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study. Eur. J. Clin. Microbiol. Infect. Dis. 15:281-285.
9. Torres, A., R. Aznar, J. M. Gatell, P. Jimenez, J. Gonzalez, A. Ferrer, R. Celis, and R. Rodriguez-Roisin. 1990. Incidence, risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am. Rev. Respir. Dis. 142:523-528.
10. Celis, R., A. Torres, J. H. Gatell, M. Almela, R. Rodriguez-Roisin, and A. Augusti-Vidal. 1988. Nosocomial pneumonia: a multivariate analysis of risk and prognosis. Chest 93:318-324.
11. Kollef, M. H. 1993. Ventilator-associated pneumonia: a multivariate analysis. J.A.M.A. 270:1965-1970.
12. Alvarez-Lerma, F., and the ICU-Acquired Pneumonia Study Group. 1996. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the ICU. Intensive Care Med. 22:387-394.
13. Chastre, J., F. Viau, P. Brun, J. Pierre, M. C. Dauge, A. Bouchama, A. Akesbi, and C. Gibert. 1984. Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients. Am. Rev. Respir. Dis. 130:924-929.
14. Fagon, J. Y., J. Chastre, A. J. Hance, M. Guiguet, J. L. Trouillet, Y. Domart, J. Pierre, and C. Gibert. 1988. Detection of nosocomial lung infection in ventilated patients: use of a protected specimen brush and quantitative culture techniques in 147 patients. Am. Rev. Respir. Dis. 138:110-116.
15. Chastre, J., J. Y. Fagon, M. Bornet-Lecso, S. Calvat, M. C. Dombret, R. A. Khani, F. Basset, and C. Gibert. 1995. Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. Am. J. Respir. Crit. Care Med. 152:231-240.
16. Chastre, J., J. Y. Fagon, and J. L. Trouillet. 1995. Diagnosis and treatment of nosocomial pneumonia in patients in intensive care units. Clin. Infect. Dis. 21(Suppl. 3):S226-S237.
17. McCabe, W. R., and G. G. Jackson. 1982. Gram-negative bacteremia, I. Arch. Intern. Med. 110:847-864.
18. Zwillich, C., D. Pierson, C. Creagh, S. Sutton, E. Schatz, and T. Petty. 1974. Complications of assisted ventilation: a prospective study of 354 consecutive episodes. Am. J. Med. 57:161-170.
19. Bone, R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. H. Schein, and W. J. Sibbald. 1992. Definitions for sepsis and organ failure and guidelines for use of innovative therapies in sepsis. Chest 101:1644-1655.
20. Legall, J. R., S. Lemeshow, and F. Saulnier. 1993. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. J.A.M.A. 270:2957-2963.
21. Knauss, W. A., E. A. Drapper, D. P. Wagner, and J. E. Zimmerman. 1985. Apache II: a severity of disease classification system. Crit. Care Med. 13:818-829.
22. Fagon, J. Y., J. Chastre, A. Novara, P. Medioni, and C. Gibert. 1993. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intensive Care Med. 19:137-144.
23. Hanley, J. A., and B. J. McNeil. 1983. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148:839-843.
24. Fagon, J. Y., J. Chastre, Y. Domart, J. L. Trouillet, J. Pierre, C. Darne, and C. Gibert. 1989. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am. Rev. Respir. Dis. 139:887-894.
25. Prod'hom, G., P. Leuenberger, J. Koerfer, A. Blum, R. Chiolero, M. D. Schaller, C. Perret, O. Spinnler, J. Blondel, H. Siegrist, L. Saghafi, D. Blanc, and P. Francioli. 1994. Nosocomial pneumonia in mechanically ventilated patients receiving antiacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. Ann. Intern. Med. 120:653-662.
26. Baker, A. M., J. W. Meredith, and E. F. Haponik. 1996. Pneumonia in intubated trauma patients: microbiology and outcomes. Am. J. Respir. Crit. Care Med. 153:343-349.
27. Kollef, M. H., P. Silver, D. M. Murphy, and E. Trouillon. 1995. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 108:1655-1662.
28. Chevret, S., M. Hemmer, J. Carlet, M. Langer, and the European Cooperative Group on Nosocomial Pneumonia. 1993. Incidence and risk factors of pneumonia acquired in intensive care units: results from a multicenter prospective study on 996 patients. Intensive Care Med. 19:256-264.
29. Rello, J., A. Torres, M. Ricart, J. Vallés, D. Gonzalez, A. Artigas, and R. Rodriguez-Roisin. 1994. Ventilator-associated pneumonia by Staphylococcus aureus: comparison of methicillin-resistant and methicillin-sensitive episodes. Am. J. Respir. Crit. Care Med. 150:1545-1549.
30. Rello, J., V. Ausina, M. Ricart, J. Castella, and G. Prats. 1993. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator associated pneumonia. Chest 104:1230-1235.
31. Jones, R. N. 1996. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am. J. Med. 100(Suppl. 6A):3S-12S.
32. Ballow, C. H., and J. J. Schentag. 1992. Trends in antibiotic utilization and bacterial resistance. Diagn. Microbiol. Infect. Dis. 15:37S-42S.
33. Jacobson, K., S. H. Cohen, J. F. Inciardi, J. H. King, W. E. Lippert, T. Iglesias, and C. J. Vancouwenberghe. 1995. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group 1 β-lactamase-producing organisms. Clin. Infect. Dis. 21:1107-1113.